Lotus Eye Hospital and Institute Ltd
NSE:LOTUSEYE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Lotus Eye Hospital and Institute Ltd
Cash from Operating Activities
Lotus Eye Hospital and Institute Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Lotus Eye Hospital and Institute Ltd
NSE:LOTUSEYE
|
Cash from Operating Activities
₹27m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
1%
|
|
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
Cash from Operating Activities
₹21.4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
11%
|
CAGR 10-Years
16%
|
|
|
F
|
Fortis Healthcare Ltd
NSE:FORTIS
|
Cash from Operating Activities
₹15.7B
|
CAGR 3-Years
30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
Cash from Operating Activities
₹17.2B
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Narayana Hrudayalaya Ltd
NSE:NH
|
Cash from Operating Activities
₹10.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
G
|
Global Health Ltd
NSE:MEDANTA
|
Cash from Operating Activities
₹6.2B
|
CAGR 3-Years
26%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Lotus Eye Hospital and Institute Ltd
Glance View
Lotus Eye Hospital & Institute Ltd. engages in the provision of eye care and related services. The company is headquartered in Coimbatore, Tamil Nadu. The company went IPO on 2008-07-11. The firm operates primarily in the field of ophthalmology (Eye) and its related operation. The firm has equipped specialty clinics, such as Cataract, Glaucoma, Cornea, Pediatric Ophthalmology, Retina and Oculoplasty. The company also has a LASIK Centre which is equipped with ALCON’s WaveLight Ex500 Excimer Laser which provides the technology for an advanced LASIK procedure. The Company’s services include clinical services, patient services and allied services. Clinical service provides eye care, cataract, cornea, glaucoma, retina, oculoplasty, pediatric, ophthalmology and strabismus, refractive surgery (LASIK, PRK, ASA, LASEK), community ophthalmology and low vision aid. Patient service offers both out-patient services and in-patient services. Its allied service operates lotus ayurvedic center and optical center.
See Also
What is Lotus Eye Hospital and Institute Ltd's Cash from Operating Activities?
Cash from Operating Activities
27m
INR
Based on the financial report for Mar 31, 2025, Lotus Eye Hospital and Institute Ltd's Cash from Operating Activities amounts to 27m INR.
What is Lotus Eye Hospital and Institute Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
1%
Over the last year, the Cash from Operating Activities growth was -53%. The average annual Cash from Operating Activities growth rates for Lotus Eye Hospital and Institute Ltd have been -15% over the past three years , -11% over the past five years , and 1% over the past ten years .
